As we mentioned above, this is the first study to do so, and we do believe this topic is important, relevant to the daily problems encountered by clinicians in locally advanced luminal B HER2-negative BC in Indonesia, and could be researched in the future with some of the considerations above. The gene discussed is ERBB2; the disease is breast cancer.